Paper745017
Recent observations on the clinical pharmacology of (-)deprenyl.
Stern GM and 2 others. J Neural Transm, 1978. Cited by 59 papers, by iCite.
11 sourcespapers-2026-11-12-0.1.0
Cite this record
ConductScience Library. Recent observations on the clinical pharmacology of (-)deprenyl. Papers, record 745017. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/745017
Paper
PubMed's record of the paper, with iCite's citation figures. No abstract is shown.
Topics13
NLM's MeSH indexing of the paper, its major topics first.
| MeSH term | Major |
|---|---|
| Parkinson Disease | Major topic |
| Phenethylamines | Major topic |
| Selegiline | Major topic |
| Adult | |
| Aged | |
| Blood Pressure | |
| Drug Therapy, Combination | |
| Heart Rate | |
| Humans | |
| Levodopa | |
| Middle Aged | |
| Time Factors | |
| Tyramine |
Source PubMed
References10
The papers the reference list in PubMed's record names, those in our copy of PubMed, in the list's order.
| Order | PMID | Title | Journal | Year | In Papers | Source |
|---|---|---|---|---|---|---|
| 1 | 4,943,186 | Interactions between sympathomimetic amines and a new monoamine oxidase inhibitor. | Psychopharmacologia | 1970 | https://conductscience.org/library/papers/4943186 | PubMed |
| 2 | 71,602 | Deprenyl in Parkinson's disease. | Lancet | 1977 | https://conductscience.org/library/papers/71602 | PubMed |
| 3 | 65,560 | Implications of combined treatment with 'Madopar' and L-deprenil in Parkinson's disease. A long-term study. | Lancet | 1977 | https://conductscience.org/library/papers/65560 | PubMed |
| 4 | 656,120 | Deprenil: loss of selectivity for inhibition of B-type MAO after repeated treatment. | Biochem Pharmacol | 1978 | https://conductscience.org/library/papers/656120 | PubMed |
| 5 | 96,466 | Deprenyl administration in man: a selective monoamine oxidase B inhibitor without the 'cheese effect'. | Psychopharmacology (Berl) | 1978 | https://conductscience.org/library/papers/96466 | PubMed |
| 6 | 4,403,272 | The role of monoamines and acetylcholine-containing neurons in the regulation of the sleep-waking cycle. | Ergeb Physiol | 1972 | https://conductscience.org/library/papers/4403272 | PubMed |
| 7 | 728,327 | Deprenyl is metabolized to methamphetamine and amphetamine in man. | Br J Clin Pharmacol | 1978 | https://conductscience.org/library/papers/728327 | PubMed |
| 8 | 1,172,524 | The potentiation of the anti akinetic effect after L-dopa treatment by an inhibitor of MAO-B, Deprenil. | J Neural Transm | 1975 | https://conductscience.org/library/papers/1172524 | PubMed |
| 9 | 4,155,234 | The clinical physiology of side effects in long-term L-DOPA therapy. | Adv Neurol | 1974 | https://conductscience.org/library/papers/4155234 | PubMed |
| 10 | 11,422,885 | Proposed supplements and amendments to 'A Manual of Standardized Terminology, Techniques and Scoring System for Sleep Stages of Human Subjects', the Rechtschaffen & Kales (1968) standard. | Psychiatry Clin Neurosci | 2001 | https://conductscience.org/library/papers/11422885 | PubMed |
Cited by12
The papers in our copy of PubMed whose reference list names this one, newest first. iCite, which reads more sources, counts 59 citations.
| PMID | Title | Journal | Year | In Papers | Source |
|---|---|---|---|---|---|
| 34,784,871 | How to Optimize the Effectiveness and Safety of Parkinson's Disease Therapy? - A Systematic Review of Drugs Interactions with Food and Dietary Supplements. | Curr Neuropharmacol | 2022 | https://conductscience.org/library/papers/34784871 | PubMed |
| 20,614,454 | Evaluation of the efficacy and safety of adjuvant treatment to levodopa therapy in Parkinson s disease patients with motor complications. | Cochrane Database Syst Rev | 2010 | https://conductscience.org/library/papers/20614454 | PubMed |
| 9,673,855 | Safety of selegiline (deprenyl) in the treatment of Parkinson's disease. | Drug Saf | 1998 | https://conductscience.org/library/papers/9673855 | PubMed |
| 9,067,124 | Drug-induced sleep disturbances. Focus on nonpsychotropic medications. | Drug Saf | 1997 | https://conductscience.org/library/papers/9067124 | PubMed |
| 7,264,627 | Treatment of Parkinson's disease: problems with a progressing disease. | J Neural Transm | 1981 | https://conductscience.org/library/papers/7264627 | PubMed |
| 6,809,891 | The contribution of amphetamine metabolites of (-)-deprenyl to its antiparkinsonian properties. | J Neural Transm | 1982 | https://conductscience.org/library/papers/6809891 | PubMed |
| 6,766,730 | Deprenyl is a selective inhibitor of brain MAO-B in the long-term treatment of Parkinsons's disease. | Br J Clin Pharmacol | 1980 | https://conductscience.org/library/papers/6766730 | PubMed |
| 3,929,314 | Tyramine pressor sensitivity changes during deprenyl treatment. | Psychopharmacology (Berl) | 1985 | https://conductscience.org/library/papers/3929314 | PubMed |
| 2,436,247 | Dose-dependent effects of deprenyl on CSF monoamine metabolites in patients with Alzheimer's disease. | Psychopharmacology (Berl) | 1987 | https://conductscience.org/library/papers/2436247 | PubMed |
| 2,413,370 | The neuropharmacological profile of N-methyl-N-propargyl-2-aminotetralin: a potent monoamine oxidase inhibitor. | Naunyn Schmiedebergs Arch Pharmacol | 1985 | https://conductscience.org/library/papers/2413370 | PubMed |
| 2,112,994 | Selegiline and Parkinson's disease. Protective and symptomatic considerations. | Drugs | 1990 | https://conductscience.org/library/papers/2112994 | PubMed |
| 745,013 | Absence of "cheese effect" during deprenyl therapy: some recent studies. | J Neural Transm | 1978 | https://conductscience.org/library/papers/745013 | PubMed |
Data dates
The date of each source this release read.
- Trials
- 2026-11-12
- Gene search
- 2026-11-11
- Pipelines
- 2026-09-18
None in this release
- Grants
- Trials
- Comments and corrections
- Genes
- Drugs
- Data
Sources 11
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- HGNCCC0
- iCiteCC BY 4.0
- NCBI GenePublic domain (US government)
- NIH RePORTER's grant and paper linksPublic domain
- Open TargetsCC0 1.0
- PMC's ID filePublic domain (US government)
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- HGNCCC0: https://www.genenames.org/about/license/
- iCiteCC BY 4.0
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this paper from software.
The record and each of its lists are JSON, twenty rows a page. No key.
GET https://conductscience.org/api/papers/v1/745017
GET https://conductscience.org/api/papers/v1/745017/authors